Uptake of CCR7 by KIR2DS4+ NK cells is induced upon recognition of certain HLA-C alleles: implication of activating KIRs in haploidentical HSCT by Simona, Simona et al.
IJAE 
Vo l .  120 ,  n .  1  (Supp lem ent) :  67,  2015
© 2015 Firenze University Press 
ht tp://www.fupress .com/ijae
ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY
Uptake of CCR7 by KIR2DS4+ NK cells is induced upon 
recognition of certain HLA-C alleles: implication of 
activating KIRs in haploidentical HSCT 
Simona Sivori1, Silvia Pesce1, Simona Carlomagno1, Michela Falco2, Lorenzo Moretta3, Emanuela 
Marcenaro1, Alessandro Moretta1
1 Dipartimento di Medicina Sperimentale - sezione Istologia, Università di Genova, Genova, Italy - 2 UOC 
Laboratorio di Immunologia clinica e sperimentale, Istituto Giannina Gaslini, Genova, Italy - 3 Istituto Giannina 
Gaslini, Istituto Giannina Gaslini, Genova, Italy
Alloreactive NK cells have been shown to play a crucial role in the successful 
therapy of high risk acute leukemias in the haplo-HSCT setting (1-4). 
Recently, we have shown that in KIR/KIR-ligand mismatched haplo-HCT a 
remarkable advantage may exist in selecting KIR2DS1+ donors to be used in C2+ 
recipients, not only for their killing capability against recipient’s leukemic cells, but 
also for their ability of killing allogeneic DC and T cell blasts, thus preventing GvHD 
and graft rejection. 
Moreover we have shown that, as previously described for KIR2DS1, also 
KIR2DS4, another activating KIR, may induce acquisition of CCR7 and migratory 
properties by human NK cells interacting with B-EBV infected cells expressing spe-
cific HLA molecules. Importantly, this de novo CCR7 expression, occurring by a mech-
anism of trogocytosis, may represent a mechanism by which alloreactive KIR2DS1+ 
or KIR2DS4+ NK cells can migrate to lymph nodes, kill recipient’s DCs and prevent 
priming of alloreactive donor’s T cells as well as induction of graft-versus-host dis-
ease (GvHD).
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